Jenburkt Pharmaceuticals Ltd share price logo

Jenburkt Pharma Share Price

BSE: 524731

Small Cap

Healthcare Sector

₹1000.05

-18.80

(-1.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Jenburkt Pharma Stock Performance

as on March 11, 2026 at 8:59 pm IST

  • Day's High

    ₹1,000.05
    ₹1,043.90

    4.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹944.00
    ₹1,410.00
    downward going graph

    5.60%

    Downside

    40.99%

    Upside

    downward going graph

Jenburkt Pharma share price movements today

Previous Close
₹1,018.85
Open
₹1,000.05
Volume
590.00
Upper Circuit
₹1,222.60
Lower Circuit
₹815.10
Day's Low - High
₹1,000.05 - ₹1,043.90
52 Week Low - High
₹944.00 - ₹1,410.00

Jenburkt Pharma Historical Returns

1 Month Return
-3.53 %
3 Month Return
-5.66 %
1 Year Return
+ 5.85 %
3 Year Return
+ 54.91 %
5 Year Return
+ 157.32 %

Jenburkt Pharma Fundamentals

as on March 11, 2026 at 3:29 pm IST

Market Cap

₹449.65 Cr

Return on Equity (ROE)

20.25

PE Ratio (TTM)

0

Return on capital employed (ROCE)

27.18

Beta (LTM)

0.59

P/B Ratio

2.6

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-8.91

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Jenburkt Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jenburkt Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Jenburkt Pharmaceuticals Ltd image
Jenburkt Pharmaceuticals Ltd
BUY449.6531.46%0.0032151
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,865.373530%0.00932
Corona Remedies Ltd image
Corona Remedies Ltd
BUY9,978.272.68%0.591491,196
Zenotech Laboratories Ltd image
Zenotech Laboratories Ltd
NA256.333.01%0.00NANA
Medicamen Organics Ltd image
Medicamen Organics Ltd
NA24.45-17.11%0.65438
See all

Market expectation of Jenburkt Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Jenburkt Pharma Stock’s Investor Sentiment and Interest

Search interest for Jenburkt Pharmaceuticals Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Jenburkt Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
35.2
29.18
38.29
35.66
38.84
32.54
41.22
36.89
41.05
35.53
45.56
43.02
Other Income
1.26
1.04
1.1
1.35
1.19
1.41
1.85
1.58
1.88
2.06
2.08
1.82
Total Income
36.45
30.21
39.38
37.01
40.03
33.94
43.07
38.47
42.93
37.58
47.64
44.84
Expenses
27.7
22.21
29.18
28.47
28.99
23.25
29.79
28.07
30.19
26.57
32.45
35.59
Operating Profit
7.5
6.97
9.11
7.19
9.85
9.29
11.43
8.82
10.86
8.96
13.11
7.43
Operating Profit Margin %
21.31%
23.89%
23.79%
20.16%
25.36%
28.55%
27.73%
23.91%
26.46%
25.22%
28.78%
17.27%
Profit Before Interest, Tax and Depreciation
8.75
8
10.2
8.54
11.04
10.7
13.28
10.4
12.74
11.01
15.18
9.24
Interest
0.08
0.07
0.07
0.07
0.06
0.11
0.12
0.11
0.11
0.11
0.11
0.12
Depreciation
0.59
0.5
0.59
0.63
0.62
0.52
0.64
0.78
0.79
0.72
0.74
0.83
Profit Before Tax
8.08
7.43
9.54
7.84
10.36
10.07
12.52
9.51
11.84
10.18
14.33
8.29
Tax Paid
1.72
2.06
2.22
2.44
2.48
2.65
2.92
3.01
3.3
2.39
4.17
2.37
Profit After Tax
6.35
5.37
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
5.93
Total Net profit including share of profit / Loss from associate company
6.35
5.37
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
5.93
EPS
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
Actual EPS
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
Adjusted EPS
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44
Diluted EPS
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
13.44

Jenburkt Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
103.31
114.67
122.64
118.89
109.29
123.98
136.75
141.97
151.69
Other Income
2.96
3.39
3.41
4.22
4.31
4.95
5.12
4.67
6.72
Total Income
106.26
118.07
126.05
123.11
113.6
128.93
141.87
146.63
158.41
Expenses
83.59
90.89
97.68
99.15
89.45
96.73
106.38
108.85
111.3
Operating Profit
19.72
23.78
24.96
19.74
19.84
27.25
30.37
33.12
40.39
Operating Profit Margin %
19.09%
20.74%
20.35%
16.6%
18.15%
21.98%
22.21%
23.33%
26.63%
Profit Before Interest, Tax and Depreciation
22.68
27.18
28.37
23.96
24.15
32.2
35.49
37.79
47.11
Interest
0.41
0.41
0.39
0.53
0.47
0.43
0.37
0.27
0.45
Depreciation
1.79
1.5
1.35
2.3
2.04
1.9
2.26
2.34
2.73
Profit Before Tax
20.48
25.27
26.63
21.13
21.64
29.87
32.86
35.18
43.93
Tax Paid
6.97
8.05
6.83
6.27
5.14
7.58
8.25
9.2
11.87
Profit After Tax
13.51
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
Total Net profit including share of profit / Loss from associate company
13.51
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Actual EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Adjusted EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Diluted EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65

Jenburkt Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
7.82
9.95
16.18
12.99
15.02
19.45
9.27
17.05
8.12
27.91
Cash Flow from Investing Activities
-0.27
-9.77
1.01
-10.53
-2.87
-18.78
-1.19
2.62
-0.59
-17.05
Cash Flow from Financing Activities
-5.42
0.68
-17.98
-2.43
-10.84
-0.72
-5.53
-21.05
-7.08
-7.62
Net Cash Flow
2.13
0.86
-0.8
0.04
1.31
-0.04
2.54
-1.37
0.47
3.24

Jenburkt Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
47.56%
47.42%
47.39%
47.23%
46.71%
46.71%
46.69%
46.68%
46.67%
46.66%
46.65%
DII
0%
0%
0%
0%
0%
0%
0.12%
0.12%
0.12%
0.12%
0.12%
Public
50.65%
51.21%
52.61%
52.77%
53.29%
53.29%
53.2%
53.2%
53.22%
53.22%
53.24%
Total Outstanding Shares
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
44,13,300
Total Shareholders
5,741
5,872
6,021
6,316
6,419
6,628
6,901
6,987
6,712
6,855
7,163

Jenburkt Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Jenburkt Pharma .

  • Jenburkt Pharmaceuticals Ltd Earnings Results

    Jenburkt Pharmaceuticals Ltd’s net profit fell -8.91% since last year same period to ₹5.93Cr in the Q3 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -41.63% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Jenburkt Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 3.32%.

    Read More about Dividends

Insights on Jenburkt Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.22% to 53.24% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Jenburkt Pharma stock has moved up by 1.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 193.5% return, outperforming this stock by 138.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 44.8% return, outperforming this stock by 38.9%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.66% to 46.65% in Dec 2025 quarter

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd. is a well-established healthcare and pharmaceutical venture, formed by the Bhuta family in 1985. By being listed on the Bombay Stock Exchange, Jenburkt is a public limited company that specializes in manufacturing and marketing high quality pharmaceutical formulations and healthcare products. Headquartered in Mumbai, Jenburkt runs all its operations from the same location.

Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.

Revenue: ₹43.02Cr as on December 2025 (Q3 FY26)
Net Profit: ₹5.93Cr as on December 2025 (Q3 FY26)
Chairperson Name: Ashish U Bhuta
OrganisationJenburkt Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish U Bhuta
E-voting on sharesClick here to vote

FAQs

What is Jenburkt Pharma share price today?

Jenburkt Pharma share price today stands at ₹1000.05 as on . Jenburkt Pharma share today touched a day high of ₹1043.9 and a low of ₹1000.05.

What is the 52 week high and 52 week low range for Jenburkt Pharma share?

Jenburkt Pharma touched a 52 week high of ₹1410 and a 52 week low of ₹944. Jenburkt Pharma share price today i.e. is trending at ₹1000.05, which is -29.07% down from its 52 week high and 5.94% up from its 52 week low.

What is Jenburkt Pharma 's market capitalisation today?

Jenburkt Pharma market capitalisation is ₹449.65 Cr as on .

How to buy Jenburkt Pharma shares?

To buy Jenburkt Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524731 or Jenburkt Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Jenburkt Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Jenburkt Pharma trading volume today?

Jenburkt Pharma trading volume is 590.00 as on . This means that 590.00 shares of Jenburkt Pharma were bought and sold on the stock market during today's trading session.